MERRIMACK PHARMACEUTICALS

Codice
MACK
Risorse esterne
Opinione della community
Prezzo Variazione Volume
3.16 -0.63 €
(-16.62%)
87030
P/E Obiettivo ad 1anno
0 9 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 20
Sell : 3

ghed Ramiro august94 Simone Bonzanini Eugene Tackleberry P18634 Niko91 maggieramon cfalco Matteo Berci

Commenti


Notizie

Merrimack Pharmaceuticals employee arrested, charged with insider trading - Boston Business Journal

An employee of Cambridge biotech Merrimack Pharmaceuticals has been arrested and criminally charged with insider trading. The charges against Westford, Massachusetts resident Songjiang Wang were first reported by Reuters on Tuesday afternoon and ... Leggi

Trading Covered Calls: Merrimack Pharmaceuticals Inc (NASDAQ:MACK) : Covered Calls, Earnings and Intelligence - CML News

As we look at Merrimack Pharmaceuticals Inc we note that a covered call is one of the most common implementations of an option strategy, but the analysis completed when employing the covered call often times lacks the necessary rigor especially ...altro » Leggi

Analyst Advice And Earnings Insight: Civeo Corporation (NYSE:CVEO), Merrimack Pharmaceuticals, Inc. (NASDAQ ... - Post Analyst

Turning to Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), its shares were trading at $3.18 a retreat of $-0.01, on the trading floor. The stock, after opening at $3.19, touched a high of $3.23 before paring much of its gains. So far, analysts are ...altro » Leggi

Gigamon Inc (NYSE:GIMO) & Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Traders Alert - Daily News Journal (press release)

On Friday, Shares of Gigamon Inc (NYSE:GIMO) gained 1.71% to $35.60. The share price is trading in a range of $34.70 – 35.90. The stock exchanged hands with 1.26 million shares contrast to its average daily volume of 1.81 million shares. Gigamon Inc.altro » Leggi

Trading Options During Earnings in Merrimack Pharmaceuticals Inc (NASDAQ:MACK) - CML News

We're going to examine buying and selling out of the money strangles in Merrimack Pharmaceuticals Inc and find out once and for all what the winning trades have been during earnings releases. With the right tool kit it's easy to find an explicit answer ...altro » Leggi

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Files An 8-K Termination of a Material Definitive Agreement - Market Exclusive

On February 6, 2017, Merrimack Pharmaceuticals, Inc. (the “Company”) terminated the Consulting and Confidentiality Agreement, dated as of October 3, 2016, between the Company and Robert Mulroy, the Company's former President and Chief Executive ...altro » Leggi

Stock Price of Merrimack Pharmaceuticals, Inc. (MACK) Decreases -1.85% - Highland Mirror

Company shares have received an average consensus rating of Hold for the current week Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) has tumbled 1.85% during the past week, however, the bigger picture is still very bullish; the stocks have advanced and ... Leggi

Option Trading: Merrimack Pharmaceuticals Inc (NASDAQ:MACK ... - CML News

We're going to look at a wonderful result using short put spreads for Merrimack Pharmaceuticals Inc by pinpointing earnings risk, and then navigating around it. Leggi

Successful Earnings Option Trading: Merrimack Pharmaceuticals Inc (NASDAQ:MACK) - CML News

As we look at Merrimack Pharmaceuticals Inc we note that a short put is one of the most common implementations of an option strategy, but the analysis completed when employing the short put often times lacks the necessary rigor especially surrounding ...altro » Leggi

Zacks estimated an EPS of $3 for Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) - TopChronicle

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) traded with the volume of 1.35 Million in the previous trading session. The Stock opened its session at $3.13 and closed at $3.17 by showing increase of 0.96 percent. Merrimack Pharmaceuticals, Inc. has 1 ... Leggi